132 related articles for article (PubMed ID: 24019862)
21. Metastatic tumor cells detection and anti-metastatic potential with vesicular stomatitis virus in immunocompetent murine model of osteosarcoma.
Johan MP; Kubo T; Furuta T; Sakuda T; Sakaguchi T; Nakanishi M; Ochi M; Adachi N
J Orthop Res; 2018 Sep; 36(9):2562-2569. PubMed ID: 29637599
[TBL] [Abstract][Full Text] [Related]
22. Characterization and evaluation of a new oncolytic vaccinia virus strain LIVP6.1.1 for canine cancer therapy.
Gentschev I; Patil SS; Adelfinger M; Weibel S; Geissinger U; Frentzen A; Chen NG; Yu YA; Zhang Q; Ogilvie G; Szalay AA
Bioengineered; 2013; 4(2):84-9. PubMed ID: 23093804
[TBL] [Abstract][Full Text] [Related]
23. Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneity.
Pelin A; Boulton S; Tamming LA; Bell JC; Singaravelu R
Expert Opin Biol Ther; 2020 Sep; 20(9):1083-1097. PubMed ID: 32297534
[TBL] [Abstract][Full Text] [Related]
24. Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers.
Draganov DD; Santidrian AF; Minev I; Nguyen D; Kilinc MO; Petrov I; Vyalkova A; Lander E; Berman M; Minev B; Szalay AA
J Transl Med; 2019 Mar; 17(1):100. PubMed ID: 30917829
[TBL] [Abstract][Full Text] [Related]
25. Primary Human B Cells at Different Differentiation and Maturation Stages Exhibit Distinct Susceptibilities to Vaccinia Virus Binding and Infection.
Shepherd N; Lan J; Li W; Rane S; Yu Q
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292245
[TBL] [Abstract][Full Text] [Related]
26. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.
Gentschev I; Stritzker J; Hofmann E; Weibel S; Yu YA; Chen N; Zhang Q; Bullerdiek J; Nolte I; Szalay AA
Cancer Gene Ther; 2009 Apr; 16(4):320-8. PubMed ID: 18949014
[TBL] [Abstract][Full Text] [Related]
27. Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies.
Autio K; Knuuttila A; Kipar A; Ahonen M; Parviainen S; Diaconu I; Kanerva A; Hakonen T; Vähä-Koskela M; Hemminki A
Vet Comp Oncol; 2016 Dec; 14(4):395-408. PubMed ID: 25302859
[TBL] [Abstract][Full Text] [Related]
28. Double-deleted vaccinia virus in virotherapy for refractory and metastatic pediatric solid tumors.
Lun X; Ruan Y; Jayanthan A; Liu DJ; Singh A; Trippett T; Bell J; Forsyth P; Johnston RN; Narendran A
Mol Oncol; 2013 Oct; 7(5):944-54. PubMed ID: 23816608
[TBL] [Abstract][Full Text] [Related]
29. Vaccinia virus GLV-1h153 is effective in treating and preventing metastatic triple-negative breast cancer.
Gholami S; Chen CH; Lou E; De Brot M; Fujisawa S; Chen NG; Szalay AA; Fong Y
Ann Surg; 2012 Sep; 256(3):437-45. PubMed ID: 22868370
[TBL] [Abstract][Full Text] [Related]
30. Enhancing Expression of Functional Human Sodium Iodide Symporter and Somatostatin Receptor in Recombinant Oncolytic Vaccinia Virus for In Vivo Imaging of Tumors.
Wang J; Arulanandam R; Wassenaar R; Falls T; Petryk J; Paget J; Garson K; Cemeus C; Vanderhyden BC; Wells RG; Bell JC; Le Boeuf F
J Nucl Med; 2017 Feb; 58(2):221-227. PubMed ID: 27635026
[TBL] [Abstract][Full Text] [Related]
31. Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene.
Chalikonda S; Kivlen MH; O'Malley ME; Eric Dong XD; McCart JA; Gorry MC; Yin XY; Brown CK; Zeh HJ; Guo ZS; Bartlett DL
Cancer Gene Ther; 2008 Feb; 15(2):115-25. PubMed ID: 18084242
[TBL] [Abstract][Full Text] [Related]
32. Tumor vascularization is critical for oncolytic vaccinia virus treatment of peritoneal carcinomatosis.
Ottolino-Perry K; Tang N; Head R; Ng C; Arulanandam R; Angarita FA; Acuna SA; Chen Y; Bell J; Dacosta RS; McCart JA
Int J Cancer; 2014 Feb; 134(3):717-30. PubMed ID: 23893655
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice.
Gil M; Bieniasz M; Seshadri M; Fisher D; Ciesielski MJ; Chen Y; Pandey RK; Kozbor D
Br J Cancer; 2011 Nov; 105(10):1512-21. PubMed ID: 21989183
[TBL] [Abstract][Full Text] [Related]
34. Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium.
Buckel L; Advani SJ; Frentzen A; Zhang Q; Yu YA; Chen NG; Ehrig K; Stritzker J; Mundt AJ; Szalay AA
Int J Cancer; 2013 Dec; 133(12):2989-99. PubMed ID: 23729266
[TBL] [Abstract][Full Text] [Related]
35. Preferential colonization of metastases by oncolytic vaccinia virus strain GLV-1h68 in a human PC-3 prostate cancer model in nude mice.
Donat U; Weibel S; Hess M; Stritzker J; Härtl B; Sturm JB; Chen NG; Gentschev I; Szalay AA
PLoS One; 2012; 7(9):e45942. PubMed ID: 23049897
[TBL] [Abstract][Full Text] [Related]
36. Deciphering the Immunomodulatory Capacity of Oncolytic Vaccinia Virus to Enhance the Immune Response to Breast Cancer.
Umer BA; Noyce RS; Franczak BC; Shenouda MM; Kelly RG; Favis NA; Desaulniers M; Baldwin TA; Hitt MM; Evans DH
Cancer Immunol Res; 2020 May; 8(5):618-631. PubMed ID: 32127390
[TBL] [Abstract][Full Text] [Related]
37. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68.
Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA
PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374
[TBL] [Abstract][Full Text] [Related]
38. Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma.
Pugalenthi A; Mojica K; Ady JW; Johnsen C; Love D; Chen NG; Aguilar RJ; Szalay AA; Fong Y
Cancer Gene Ther; 2015 Dec; 22(12):591-6. PubMed ID: 26584530
[TBL] [Abstract][Full Text] [Related]
39. Engineering oncolytic vaccinia virus with functional peptides through mild and universal strategy.
Huang LL; Li X; Liu K; Zou B; Xie HY
Anal Bioanal Chem; 2019 Feb; 411(4):925-933. PubMed ID: 30523361
[TBL] [Abstract][Full Text] [Related]
40. Use of GLV-1h68 for Vaccinia Virotherapy and Monitoring.
Frentzen A; Geissinger U; Tsoneva D; Stritzker J
Methods Mol Biol; 2015; 1317():225-37. PubMed ID: 26072410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
